ACADIA Pharmaceuticals, Inc.

NUPLAZID: The first and only approved therapy for hallucinations and delusions associated with Parkinson Disease Psychosis.

ACADIA is trailblazing breakthroughs in neuroscience to elevate life through science.
Our care-ageous family aspires to enable bright moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.